KEAP1 and breast carcinoma: Interestingly, the reconstitution of CAV-1 expression in MCF-7 breast cancer cells that are normally defective for this protein was sufficient to suppress the NRF2 activity by promoting its interaction with KEAP1 and, consequently, its faster degradation, an event ultimately leading to a decreased SOD-2 expression.